Cargando…
A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo
The lack of animal models for some human diseases precludes our understanding of disease mechanisms and our ability to test prospective therapies in vivo. Generation of kidney organoids from Tuberous Sclerosis Complex (TSC) patient-derived-hiPSCs allows us to recapitulate a rare kidney tumor called...
Autores principales: | Hernandez, J. O. R., Wang, X., Vazquez-Segoviano, M., Lopez-Marfil, M., Sobral-Reyes, M. F., Moran-Horowich, A., Sundberg, M., Lopez-Cantu, D. O., Probst, C. K., Ruiz-Esparza, G. U., Giannikou, K., Abdi, R., Henske, E. P., Kwiatkowski, D. J., Sahin, M., Lemos, D. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586030/ https://www.ncbi.nlm.nih.gov/pubmed/34764250 http://dx.doi.org/10.1038/s41467-021-26596-y |
Ejemplares similares
-
Bioengineered nisin derivatives with enhanced activity in complex matrices
por: Rouse, Susan, et al.
Publicado: (2012) -
Extreme bioengineering to meet the nitrogen challenge
por: Burén, Stefan, et al.
Publicado: (2018) -
A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius
por: Field, Des, et al.
Publicado: (2015) -
Bioengineering Lantibiotics for Therapeutic Success
por: Field, Des, et al.
Publicado: (2015) -
Transforming bioengineering with unbiased teams and tools
por: Jewell, Christopher M., et al.
Publicado: (2023)